https://www.selleckchem.com/products/SGX-523.html
A well designed, adequately powered, randomised controlled trial published in 2019 also definitively demonstrated that there was no increase in death, myocardial infarction or repeat revascularisation with endoscopic vein harvest. Endoscopic vein harvest is a Class IIa indication in European Association of Cardio-Thoracic Surgery (EACTS) and a Class I indication in International Society of Minimally Invasive Cardiac Surgery (ISMICS) guidelines.Due to its potential benefits and increased patient satisfaction minimal invasive cardiac surg
Beğen
Yorum Yap
Paylaş
